Community-Acquired Pneumonia in Adults: Guidelines on Diagnosis, Treatment and Prophylaxis

Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(1):54-86

​ Chuchalin A.G., Sinopalnikov A.I., Stratchounski L.S., Kozlov R.S., Rachina S.A., Yakovlev S.V.
community-acquired pneumonia diagnosis treatment prophylaxis guidelines
Section
Guidelines
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(1):54-86

Abstract

These guidelines are a result of consensus expert opinion based on peer review of the literature published over the last 10 years. References include a number of international guidelines for the management of adults in community-acquired pneumonia (CAP): British Thoracic Society (BTS, 2001, 2004), European Respiratory Society (ERS, 1998, 2005), Infectious Diseases Society of America (IDSA, 2000, 2003), American Thoracic Society (ATS, 2001), Canadian Infectious Diseases Society/Canadian Thoracic Society (CIDS/CTS, 2000), US Centers for Disease Control and Prevention (CDC, 2001). The national consensus guidelines for the management of CAP in adults, developed by the experts of Russian Respiratory Society, Interregional Association of Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), and Alliance of Clinical Chemotherapy and Microbiology, were first issued in 2003. However, authors realized that this document needs to be revised and updated because of changing concept of CAP. The second issue of the national guidelines contains data on epidemiology of CAP and new information about resistance of key respiratory pathogens in Russia (Streptococcus pneumoniae and Haemophilus influenzae). Moreover, sections about etiology and diagnosis of CAP were updated, and new sections including the description of the main antimicrobial classes, review of real clinical practice of the CAP management, and quality indicators were also added.

  • 1. Huchon G., Woodhead M. and the ERS Task Force. Guidelines for management of adult community-acquired lower respiratory tract infections. Eur Respir J 1998; 11:986-91.
  • 2. Bartlett J.G., Dowell S.F., Mandell L.A., et al. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000; 31: 347-82.
  • 3. Mandell L.A., Marrie T.J., Grossman R.F., Chow A.W., Hyland R.H., the Canadian Community-Acquired Pneumonia Working Group. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 2000; 31:383-421.
  • 4. Niederman M.S., Mandell L.A., Anzueto A., et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163:1730-54.
  • 5. British Thoracic Society Guidelines for the management of community-acquired pneumonia in adults. Thorax 2001; 56(Suppl. 4):1-64.
  • 6. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). Mortal. Morbid. Wkly Rep 1997; 46(R-8).
  • 7. Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Mortal. Morbid. Wkly Rep. Recomm Rep 2005; 54(RR-8):1-40.
  • 8. Mandell L., Bartlett J., Dowell S., et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003; 37:1405-33.
  • 9. British Thoracic Society guidelines for the management of community-acquired pneumonia in adults – 2004 update. Available from: www.brit-thoracic.org.uk
  • 10. Клинические рекомендации. Внебольничная пневмония у взрослых / Под ред. А.Г. Чучалина, А.И. Синопальникова – М.: Атмосфера, 2005.
  • 11. Metlay J. P., Fine M.J. Testing strategies in the initial management of patient with community-acquired pneumonia. Ann Intern Med 2003; 138:109-18.
  • 12. Гучев И.А., Раков А.Л., Синопальников А.И. и др. Влияние химиопрофилактики на заболеваемость пневмонией в организованном коллективе. Военно-мед журн 2003; 3:54-61.
  • 13. Fine M.J., Smith M.A., Carson C.A., et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996; 275:134-41.
  • 14. Heffelfinger J.D., Dowell S.F., Jorgensen J.H., et al. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant S. pneumoniae Therapeutic Working Group. Arch Intern Med 2000; 160:1399-408.
  • 15. Low D.E. Trends and significance of antimicrobial resistance in respiratory pathogens. Curr Opin Infect Dis 2000; 13:145-53.
  • 16. Metlay J.P. Update of community-acquired pneumonia: impact of antibiotic resistance on clinical outcomes. Curr Opin Infect Dis 2002; 15:163-67.
  • 17. Kozlov R.S.,Stratchounski L.S., Sivaja O.V.7-years monitoring of resistance of clinical S.pneumoniae in Russia: results of prospective multicenter study (PEHASus). Proceedings of 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2005 Dec 15-19; Washington DC, USA. Abstr. C2-249.
  • 18. Andes D. Pharmacokinetic and pharmacodynamic properties of antimicrobials in the therapy of respiratory tract infectious. Curr Opin Infect Dis 2001; 14:165-72.
  • 19. Практическое руководство по антиинфекционной химиотерапии / Под редакцией Л.С. Страчунского, Ю.Б. Белоусова, С.Н. Козлова. М.: Боргес, 2002.
  • 20. Metersky M.L. Community-acquired pneumonia: process of care studies. Curr Opin Infect Dis 2002; 15:169-74.
  • 21. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58:377-82.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared